ArriVent BioPharma, Inc. Common Stock
AVBP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$80,488 | -$69,333 | -$36,906 | -$51,606 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $3,208 | $895 | $424 | $0 |
| Change in WC | $7,068 | $12,596 | -$7,149 | -$3,941 |
| Other Non-Cash | $0 | $0 | $0 | $42,960 |
| Operating Cash Flow | -$70,212 | -$55,842 | -$43,631 | -$12,587 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$194,164 | -$25,000 | $0 | $0 |
| Inv. Sales/Matur. | $1,699 | $25,000 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | -$40,000 |
| Investing Cash Flow | -$192,465 | $0 | $0 | -$40,000 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $185,950 | $0 | $2 | $89,867 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $631 | $42,859 | $169,721 | $0 |
| Financing Cash Flow | $186,581 | $42,859 | $169,723 | $89,867 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$76,096 | -$12,983 | $126,092 | $37,280 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $150,389 | $163,372 | $37,280 | $0 |
| End Cash | $74,293 | $150,389 | $163,372 | $37,280 |
| Free Cash Flow | -$70,212 | -$55,842 | -$43,631 | -$12,587 |